Daily Online Bony Correction is Required for Prostate Patients Without Fiducial Markers or Soft-tissue Imaging

Clinical Oncology

Volumn 23, Issue 7, 2011, Pages 454-459

  Johnston, M L ^a   Vial, P ^a,b,d,e   Wiltshire, K L ^a,f   Bell, L J ^a   Blome, S ^a   Kerestes, Z ^a   Morgan, G W ^a   O'Driscoll, D ^a   Shakespeare, T P ^a,c   Eade, T N ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Department of Radiation Oncology   (Australia)

^d Department of Medical Physics ^*  (United Kingdom)

^e MacCarthur Cancer Therapy Centres   (Australia)

^f PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Bony anatomy; Fiducial marker; Online correction; Prostate radiotherapy

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; DISEASE MARKER; HUMAN; IMAGE ANALYSIS; LASER; MAJOR CLINICAL STUDY; MALE; ONLINE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SOFT TISSUE RADIOGRAPHY; TATTOO;

FIDUCIAL MARKERS; HUMANS; MALE; PELVIC BONES; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 79960929946     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.02.013     Document Type: Article

References (28)

1. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001, 166:876-881.
2. Kupelian P.A., Lee C., Langen K.M., et al. Evaluation of image-guidance strategies in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:1151-1157.
3. de Boer H.C.J., van Os M.J.H., Jansen P.P., et al. Application of the No Action Level (NAL) protocol to correct for prostate motion on electronic portal imaging of implanted markers. Int J Radiat Oncol Biol Phys 2005, 61:969-983.
4. Langen K.M., Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys 2001, 50:265-278.
5. Chung P.W., Haycocks T., Brown T., et al. Online aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 2004, 60:329-334.
6. Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 2003, 67:295-302.
7. Nederveen A.J., Dehnad H., van der Heide U.A., et al. Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother Oncol 2003, 68:81-88.
8. Sorcini B., Tilikidis A. Clinical application of image-guided radiotherapy, IGRT (on the Varian OBI platform). Cancer Radiother 2006, 10:252-257.
9. Van den Heuvel F., Fugazzi J., Seppi E., et al. Clinical application of a repositioning scheme, using gold markers and electronic portal imaging. Radiother Oncol 2006, 79:94-100.
10. Moseley D.J., White E.A., Wiltshire K.L., et al. Comparison of localisation performance with implanted fiducial markers and cone-beam computed tomography for online image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 2007, 67:942-953.
11. McNair H.A., Hansen V.N., Parker C.C., et al. A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2007, 71(1):41-50.
12. Graf R., Wust P., Budach V., et al. Potentials of online re-positioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy. Radiat Oncol 2009, 4:13.
13. Bell L.J., Oliver L., Vial P., et al. Implementation of an image-guided radiation therapy program: lessons learnt and future challenges. J Med Imaging Radiat Oncol 2010, 54:82-89.
14. van Herk M., Remeijer P., Rasch C., et al. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000, 47(4):1121-1135.
15. Padhani A.R., Khoo V.S., Suckling J., et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 1999, 44:525-533.
16. Willoughby T.R., Kupelian P.A., Pouliot J., et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2006, 65:528-534.
17. Chen J., Lee R.J., Handrahan D., et al. Intensity-modulated radiotherapy using implanted fiducial markers with daily portal imaging: assessment of prostate organ motion. Int J Radiat Oncol Biol Phys 2007, 68:912-919.
18. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using online isocentre set-up verification and implanted prostate markers. Radiother Oncol 2001, 61:127-133.
19. Poli M.E.R., Parker W., Patrocinio H., et al. An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations. Int J Radiat Oncol Biol Phys 2007, 67:1430-1437.
20. de Crevoisier R., Tucker S.L., Dong L., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:965-973.
21. Heemsbergen W.D., Hoogeman M.S., Witte M.G., et al. Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68Gy vs 78Gy. Int J Radiat Oncol Biol Phys 2007, 67(5):1418-1424.
22. de Boer H.C.J., Heijman B.J.M. A protocol for the reduction of systematic patient set-up errors with minimal portal imaging workload. Int J Radiat Oncol Biol Phys 2001, 50(5):1350-1365.
23. Roach M., De Silvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003, 21:1904-1911.
24. Haworth A., Kearval R., Greer P.B., et al. Assuring high quality treatment delivery in clinical trials - results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study. Radiother Oncol 2009, 90(3):299-306.
25. Greer P.B., Dahl K., Ebert M.A., et al. Comparison of prostate set-up accuracy and margins with offline bony anatomy corrections and online implanted fiducial-based corrections. J Med Imaging Radiat Oncol 2008, 52:511-516.
26. Schallenkamp J.M., Herman M.G., Kruse J.J., et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 2005, 63:800-811.
27. Middleton M., See A., Rolfo A., et al. Intraprostatic fiducials and image guidance: workflow implications in a single linac department. Radiography 2008, 14:312-317.
28. Button M.R., Staffurth J.N. Clinical application of image-guided radiotherapy in bladder and prostate cancer. Clin Oncol 2010, 22:698-706.